WCBD News 2

Sea turtle battles cold-stunning at S.C. Aquarium

As temperatures drop across the Lowcountry, colder waters are posing serious risks to wildlife both on land and at sea, ...

Kymera Therapeutics Announces First Patient Dosed in BREADTH Phase 2b Asthma Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader

Detailed price information for Kymera Therapeutics Inc (KYMR-Q) from The Globe and Mail including charting and trades.

Kymera Therapeutics, Inc.: Kymera Therapeutics Announces First Patient Dosed in BREADTH Phase 2b Asthma Clinical Trial of KT-621, a First-in-Class, Oral STAT6 Degrader

Data from the BREADTH Phase 2b asthma trial is expected to be reported in late-2027 Data from the ongoing parallel BROADEN2 Phase 2b atopic dermatitis trial is expected to be reported by mid-2027 WATE ...
BuzzFeed on MSN

32 totally worth the money skincare items, according to reviewers

Beauty may be pain (to your wallet), but remember, pain is temporary, and dewy, glowy skin can be forever. View Entire Post › ...
Everyday Health on MSN

Decoding your IGAN lab results: Understanding EGFR and UPCR, and predicting future kidney health

Understanding eGFR and uPCR is vital for managing IgA nephropathy to predict kidney health, guide treatment, and work ...